American Eagle Backs Away From Pacific Booker-But BKM's Strategic Review Still Isn't a Clean Bullish Call

American Eagle's termination ends the tender, not the debate

American Eagle has ended its bid. The offer terminated effective immediately, and deposited Pacific Booker shares will be promptly returned. That closes the immediate tender window, but it does not settle the larger question of how Pacific Booker should be valued or who ultimately controls the narrative.

What does remain active is Pacific Booker's own process. The board's Special Committee has completed a strategic review process, and INFOR said American Eagle's consideration was inadequate, from a financial point of view. That keeps the valuation debate alive. Even so, it is still not a clean bullish signal. Investors are still being asked to wait on uncertainty after an offer that carried an implied value of $1.76 per share.

The timeline also matters. American Eagle started its unsolicited bid on April 14, 2026. Pacific Booker formed the Special Committee on April 27, 2026, and INFOR delivered its fairness opinion by June 2. In that sense, the board was responding to the bid rather than acting ahead of it.

That leaves the core issue unresolved: where is the alignment of interest? Bulls can argue a fresh process may lead to a better outcome. Bears can argue an open strategic review with no disclosed buyer is mostly delay. For now, American Eagle has stepped back, but Pacific Booker has not yet shown what the alternative actually is.

Pacific Booker's price objection is real, but it is not proof of a better outcome

Pacific Booker is arguing the offer was too low, not that a superior deal is already in place. The board's case begins with the deal terms-1.41 American Eagle shares per BKM share-and the view that the bid did not capture Morrison's full strategic upside. Its directors said the offer fails to recognize the strategic value of the project, was lower than comparable copper-sector transactions, and deprived shareholders of upside. INFOR later supported that position with an opinion that the consideration was inadequate, from a financial point of view.

That matters because the rejection was not just defensive boardroom language. There is a documented price argument. But price inadequacy is not the same as de-risked upside. If the strategic review produces no named buyer, no term sheet, and no clear path to something better than simply waiting for another offer, the stock can still be risky even if the failed bid was genuinely too low.

Process credibility helps, but it does not settle the value question

Bulls do have a fair point here: this was not a last-minute reaction. The Special Committee was formed on April 27, 2026, and INFOR's fairness opinion arrived earlier this month rather than at the last hour. That gives the board some process credibility and suggests the rejection was not based on a single hostile headline.

Still, process credibility is not the same as capital discipline, and it is not the same as alignment of interest. Until the strategic review produces something tangible, the market is still being asked to pay for possibility rather than certainty.

American Eagle's pushback keeps the bear case alive

American Eagle is not simply walking away; it is also challenging the quality of the asset. Its shareholder materials argue the Morrison land package has been reduced by approximately 92%, that the 2009 feasibility study is invalid and cannot be relied upon, and that there is no permitting pathway under current management. Those are serious claims. If they hold up, rejecting the bid may not be obviously value-accretive. It may amount to little more than delay.

That is the real split in the story now. The offer may have been too low, but the rejection only becomes more compelling if the board can show a credible path forward, better capital discipline, and clearer alignment with shareholder interests. Until then, the terminated bid created optionality; it did not prove that optionality already has value.